5 Ways Ozempic and Other New Weight-Loss Drugs Have Changed Health
Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact
The Biggest Health and Medicine Stories of 2023
From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year
Read all the stories you want.
Weight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart Disease
The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers
How a Weight-Loss Trend on TikTok Might Encourage Eating Disorders
Laxative misuse is cropping up in wellness and weight-loss social media communities—and some experts are concerned about its close ties to eating disorders
Popular Weight-Loss Drugs Come with Side Effects
Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro
Should Insurance Cover Wegovy, Ozempic and Other New Weight-Loss Drugs?
Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone
‘Budget Ozempic’ Weight-Loss Trend Raises Safety Concerns
The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused
Weight-Loss Drug Also Protects against Heart Disease. What Happens Next?
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial
Ozempic and Other Weight-Loss Drugs Bear Heavy Costs and Questions for Seniors
Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability
Aspartame Declared ‘Possible’ Carcinogen. Here’s What That Really Means
United Nations groups say the artificial sweetener poses a possible risk of liver cancer—but there’s no evidence for harm under the current daily limit
Beyond Ozempic: New Obesity Drugs Could Be Cheaper and Even More Effective
Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now
Better Ways Than BMI to Measure Obesity
A leading medical society says that the commonly used body mass index falls short, and it is time for alternative measures